ovarian

• Opaxio is designed to reduce the side effects of paclitaxel by linking it to a biodegradable polymer to create a new chemical entity which results in targeted delivery to solid tumors such as breast, ovarian, and lung cancers. —  pfblogs.org: The Ad-Free Personal Finance Blogs Aggregator
• London, January 10: University College London (UCL) is for the first time offering tests that can detect a raised risk of breast, ovarian, and prostate cancer to people without family histories of the diseases. —  dailyindia.com News Feed
• Risk-reducing salpingo-oophorectomy (RRSO), or the preventive removal of the ovaries and fallopian tubes, is strongly associated with a reduction in the risk of breast, ovarian, and fallopian tube cancers in women who carry a BRCA mutation.
• Cancer Research UK scientists have shown for the first time how a natural 'defence' gene involved in fighting infections such as common colds, can be triggered by hormones to ignite and drive cancers like breast, ovarian, and possibly prostate cancer. —  Health News from Medical News Today
• The phase 2 trial conducted by Dr. Einstein and his colleagues©¤the first to evaluate the combination of the drugs for this purpose©¤involved 24 women with recurrent uterine, ovarian, fallopian or peritoneal cancers. —  innovations-report

Used in the Same Context